Publications by authors named "Roland Gendron"

Claim this Profile
D
Discovery of TD-0212, an Orally Active Dual Pharmacology AT Antagonist and Neprilysin Inhibitor (ARNI).
R Murray McKinnell, Paul Fatheree, Seok-Ki Choi, Roland Gendron, Keith Jendza

ACS Med Chem Lett· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.
Daniel D Long, Scott R Armstrong, David T Beattie, Seok-Ki Choi, Paul R Fatheree, Roland A L Gendron

Bioorg Med Chem Lett· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749.
Daniel D Long, Scott R Armstrong, David T Beattie, Seok-Ki Choi, Paul R Fatheree, Roland A L Gendron

Bioorg Med Chem Lett· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists.
R Murray McKinnell, Scott R Armstrong, David T Beattie, Seok-Ki Choi, Paul R Fatheree, Roland A L Gendron

J Med Chem· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis